SBI Healthcare Opportunities Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹166 Cr | ₹2760 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 14 Jul 1999 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open-ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 32% |
| Expense Ratio | 2.34 | 2 |
| Manager | Rohan Korde | Pradeep Kesavan |
| ISIN Code | INF00XX01BL5 | INF200K01446 |
| Exits Load | Exit load of 1% if redeemed within 12 months./365 | Exit load of 0.50% if redeemed within 15 days/365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Month | 6.02% | 5.72% |
| 6 Month | 20.76% | 15.48% |
| 1 Year | 49.89% | 45.23% |
| 3 Year | - | 20.72% |
| 5 Year | - | 29.9% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 14.47% | 15.2% |
| 3 Year | 35.63% | 44.51% |
| 5 Year | 35.63% | 82.64% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Year | 20.49% | 14.55% |
| 3 Year | - | 17.1% |
| 5 Year | - | 12.47% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Standard Deviation | 14.52% | 14.02% |
| Sharp | - | 0.78% |
| Beta | - | 0.87% |
| Alpha | - | 3.06% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Name | Rohan Korde | Pradeep Kesavan |
| Total AUM | ₹4626 Cr | ₹434274 Cr |
| Fund Manage | 10 | 43 |
| ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 0.48 | 8.64 |
| Mid Cap | 28.05 | 29.49 |
| Small Cap | 32.19 | 27.81 |
| Large Cap | 39.28 | 34.06 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 0.48 | 3.46 |
| Healthcare | 96.77 | 92.23 |
| Chemicals | 2.75 | 4.31 |
Top Comparisons
Franklin India Feeder - Franklin U.S. Opportunities Fund - Growth
3Y Returns4.62%
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
3Y Returns10.4%
BANDHAN Corporate Bond Fund - Regular Growth
3Y Returns5.09%
Tata Corporate Bond Fund-Regular Plan-Growth
3Y Returns0%
Kotak NASDAQ 100 Fund of Fund - Regular Plan - Growth
3Y Returns12.6%
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
3Y Returns6.22%
SBI Nifty Next 50 Index Fund - Regular Plan - Growth
3Y Returns22.87%
Aditya Birla Sun Life Nifty Smallcap 50 Index Fund-Regular Growth
3Y Returns21.22%